Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end

Vaccine

Volumn 24, Issue 44-46, 2006, Pages 6694-6696

  Hungnes, Olav ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Evolution; Influenza; Surveillance

Indexed keywords

ANTIGENICITY; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; IMMUNITY; INFLUENZA VIRUS A; INFLUENZA VIRUS A CALIFORNIA 7 2004; INFLUENZA VIRUS A NORWAY 745 2005; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEASONAL VARIATION; SPECIES COMPARISON; VIRUS DETECTION; VIRUS STRAIN;

ANTIGENS, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; NORWAY; VARIATION (GENETICS);

EID: 33846338211     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.045     Document Type: Article

References (5)

1. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Weekly Epidemiol Rec 79 (2004) 369-373
2. Ellis J.S., Sadler C.J., Laidler P., Rebelo de Andrade H., and Zambon M.C. Analysis of influenza A H3N2 strains isolated in England during 1995-1996 using polymerase chain reaction restriction. J Med Virol 51 (1997) 234-241
3. Paget J, Meijer A, Hungnes O. First influenza virus detections in Europe: 2004-2005 season, European Influenza Surveillance Scheme. Eurosurveillance Weekly [serial on the Internet], October 14, 2004;8(42):041014. Available from: http://www.eurosurveillance.org/ew/2004/041014.asp#1.
4. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Weekly Epidemiol Rec 80 (2005) 71-75
5. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305 (2004) 371-376